Literature DB >> 9434053

Somatopause and adiposity.

J O Jørgensen1, N Vahl, S Fisker, H Nørrelund, S Nielsen, R Dall, J S Christiansen.   

Abstract

Mobilization of lipids is the pivotal action of growth hormone (GH) in both children and adults. The temporal association between declining GH levels and accumulation of body fat with ageing is, therefore, interesting although the cause-effect relationship remains unknown. Recent cross-sectional data suggest that both stimulated and spontaneous GH release is predominantly predicted by the amount of abdominal fat in both men and women. The same study also shows that ageing is associated with an increased metabolic clearance rate and apparent distribution volume, both of which correlate positively with fat mass and negatively with age. Furthermore, the acute lipolytic response to a GH bolus is somewhat lower in older adults (and in women). It is, therefore, proposed that changes in life style and dietary habits, perhaps together with an age-determined reduced lipolytic responsiveness to GH, initiates fat accumulation. The increased fat mass, in turn, inhibits the release and promotes the clearance of GH thus establishing a vicious circle.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9434053     DOI: 10.1159/000191337

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  3 in total

Review 1.  Effects of growth hormone and prolactin on adipose tissue development and function.

Authors:  David J Flint; Nadine Binart; John Kopchick; Paul Kelly
Journal:  Pituitary       Date:  2003-09       Impact factor: 4.107

Review 2.  Ageing, growth hormone and physical performance.

Authors:  F Lanfranco; L Gianotti; R Giordano; M Pellegrino; M Maccario; E Arvat
Journal:  J Endocrinol Invest       Date:  2003-09       Impact factor: 4.256

3.  Inverse association between adiposity and telomere length: The Fels Longitudinal Study.

Authors:  Miryoung Lee; Hilarie Martin; Matthew A Firpo; Ellen W Demerath
Journal:  Am J Hum Biol       Date:  2011 Jan-Feb       Impact factor: 1.937

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.